Cargando…

Total Health-Related Costs Due to Absenteeism, Presenteeism, and Medical and Pharmaceutical Expenses in Japanese Employers

OBJECTIVE: This study aimed to examine a detailed breakdown of costs (absenteeism, presenteeism, and medical/pharmaceutical expenses), of the employees in four pharmaceutical companies in Japan. METHODS: This is a cross-sectional study. Absenteeism and presenteeism were measured by a self-administer...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagata, Tomohisa, Mori, Koji, Ohtani, Makoto, Nagata, Masako, Kajiki, Shigeyuki, Fujino, Yoshihisa, Matsuda, Shinya, Loeppke, Ronald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959215/
https://www.ncbi.nlm.nih.gov/pubmed/29394196
http://dx.doi.org/10.1097/JOM.0000000000001291
_version_ 1783324354086436864
author Nagata, Tomohisa
Mori, Koji
Ohtani, Makoto
Nagata, Masako
Kajiki, Shigeyuki
Fujino, Yoshihisa
Matsuda, Shinya
Loeppke, Ronald
author_facet Nagata, Tomohisa
Mori, Koji
Ohtani, Makoto
Nagata, Masako
Kajiki, Shigeyuki
Fujino, Yoshihisa
Matsuda, Shinya
Loeppke, Ronald
author_sort Nagata, Tomohisa
collection PubMed
description OBJECTIVE: This study aimed to examine a detailed breakdown of costs (absenteeism, presenteeism, and medical/pharmaceutical expenses), of the employees in four pharmaceutical companies in Japan. METHODS: This is a cross-sectional study. Absenteeism and presenteeism were measured by a self-administered questionnaire for workers, and their costs were estimated using the human capital approach. Presenteeism was evaluated by the degree affected quality and quantity of work. Medical and pharmaceutical expenses were obtained by insurance claims. RESULTS: The monetary value due to absenteeism was $520 per person per year (11%), that of presenteeism was $3055 (64%), and medical/pharmaceutical expenses were $1165 (25%). Two of the highest total cost burdens from chronic illness were related to mental (behavioral) health conditions and musculoskeletal disorders. CONCLUSION: A total cost approach can help employers set priorities for occupational health, safety, and population health management initiatives.
format Online
Article
Text
id pubmed-5959215
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-59592152018-06-01 Total Health-Related Costs Due to Absenteeism, Presenteeism, and Medical and Pharmaceutical Expenses in Japanese Employers Nagata, Tomohisa Mori, Koji Ohtani, Makoto Nagata, Masako Kajiki, Shigeyuki Fujino, Yoshihisa Matsuda, Shinya Loeppke, Ronald J Occup Environ Med Original Articles OBJECTIVE: This study aimed to examine a detailed breakdown of costs (absenteeism, presenteeism, and medical/pharmaceutical expenses), of the employees in four pharmaceutical companies in Japan. METHODS: This is a cross-sectional study. Absenteeism and presenteeism were measured by a self-administered questionnaire for workers, and their costs were estimated using the human capital approach. Presenteeism was evaluated by the degree affected quality and quantity of work. Medical and pharmaceutical expenses were obtained by insurance claims. RESULTS: The monetary value due to absenteeism was $520 per person per year (11%), that of presenteeism was $3055 (64%), and medical/pharmaceutical expenses were $1165 (25%). Two of the highest total cost burdens from chronic illness were related to mental (behavioral) health conditions and musculoskeletal disorders. CONCLUSION: A total cost approach can help employers set priorities for occupational health, safety, and population health management initiatives. Lippincott Williams & Wilkins 2018-05 2018-02-02 /pmc/articles/PMC5959215/ /pubmed/29394196 http://dx.doi.org/10.1097/JOM.0000000000001291 Text en Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American College of Occupational and Environmental Medicine. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle Original Articles
Nagata, Tomohisa
Mori, Koji
Ohtani, Makoto
Nagata, Masako
Kajiki, Shigeyuki
Fujino, Yoshihisa
Matsuda, Shinya
Loeppke, Ronald
Total Health-Related Costs Due to Absenteeism, Presenteeism, and Medical and Pharmaceutical Expenses in Japanese Employers
title Total Health-Related Costs Due to Absenteeism, Presenteeism, and Medical and Pharmaceutical Expenses in Japanese Employers
title_full Total Health-Related Costs Due to Absenteeism, Presenteeism, and Medical and Pharmaceutical Expenses in Japanese Employers
title_fullStr Total Health-Related Costs Due to Absenteeism, Presenteeism, and Medical and Pharmaceutical Expenses in Japanese Employers
title_full_unstemmed Total Health-Related Costs Due to Absenteeism, Presenteeism, and Medical and Pharmaceutical Expenses in Japanese Employers
title_short Total Health-Related Costs Due to Absenteeism, Presenteeism, and Medical and Pharmaceutical Expenses in Japanese Employers
title_sort total health-related costs due to absenteeism, presenteeism, and medical and pharmaceutical expenses in japanese employers
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959215/
https://www.ncbi.nlm.nih.gov/pubmed/29394196
http://dx.doi.org/10.1097/JOM.0000000000001291
work_keys_str_mv AT nagatatomohisa totalhealthrelatedcostsduetoabsenteeismpresenteeismandmedicalandpharmaceuticalexpensesinjapaneseemployers
AT morikoji totalhealthrelatedcostsduetoabsenteeismpresenteeismandmedicalandpharmaceuticalexpensesinjapaneseemployers
AT ohtanimakoto totalhealthrelatedcostsduetoabsenteeismpresenteeismandmedicalandpharmaceuticalexpensesinjapaneseemployers
AT nagatamasako totalhealthrelatedcostsduetoabsenteeismpresenteeismandmedicalandpharmaceuticalexpensesinjapaneseemployers
AT kajikishigeyuki totalhealthrelatedcostsduetoabsenteeismpresenteeismandmedicalandpharmaceuticalexpensesinjapaneseemployers
AT fujinoyoshihisa totalhealthrelatedcostsduetoabsenteeismpresenteeismandmedicalandpharmaceuticalexpensesinjapaneseemployers
AT matsudashinya totalhealthrelatedcostsduetoabsenteeismpresenteeismandmedicalandpharmaceuticalexpensesinjapaneseemployers
AT loeppkeronald totalhealthrelatedcostsduetoabsenteeismpresenteeismandmedicalandpharmaceuticalexpensesinjapaneseemployers